(ICCC)

Role: President and CEO, Director
Signature: /s/ Timothy C. Fiori Attorney-in-Fact
Issuer symbol: ICCC
Transactions as of: 07 Nov 2025
Net transactions value: +$453,090
Form type: 4
Filing time: 12 Nov 2025, 08:43:06 UTC
Previous filing: 07 Nov 2025
Next filing: 03 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
te Boekhorst Paul Francis Olivier	President and CEO, Director	C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND	/s/ Timothy C. Fiori Attorney-in-Fact	11 Nov 2025	0002095704

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICCC	Stock Options (right to buy)	Award	$453,090	+74,277	+98%	$6.10	150,260	07 Nov 2025	Common Stock	74,277	$6.10	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date.

Content

Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date.